Gilead Sciences (GILD) Non-Current Deferred Tax Liability (2012 - 2026)

Gilead Sciences (GILD) has reported Non-Current Deferred Tax Liability for 12 consecutive years, with $333.0 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Non-Current Deferred Tax Liability fell 48.93% year-over-year to $333.0 million; the trailing twelve-month figure through Jun 2026 stood at $333.0 million (down 48.93% YoY), and the FY2025 full-year result was $402.0 million, down 90.73% from the prior year.
• Non-Current Deferred Tax Liability declined to $333.0 million in Q2 2026 per GILD's latest filing, from $392.0 million in the prior quarter.
• Across five years, Non-Current Deferred Tax Liability topped out at $6.1 billion in Q4 2022 and bottomed at $333.0 million in Q2 2026.
• Historically, Non-Current Deferred Tax Liability has averaged $2.1 billion across 5 years, with a median of $1.5 billion in 2023.
• The sharpest annual moves came in 2023 and 2025: Non-Current Deferred Tax Liability decreased 2.99% in 2023, then tumbled 90.73% in 2025.
• Over 5 years, Non-Current Deferred Tax Liability stood at $6.1 billion in 2022, then slipped by 2.99% to $5.9 billion in 2023, then decreased by 26.99% to $4.3 billion in 2024, then plunged by 90.73% to $402.0 million in 2025, then fell by 17.16% to $333.0 million in 2026.
• According to Business Quant data, Non-Current Deferred Tax Liability over the past three periods registered $333.0 million, $392.0 million, and $402.0 million for Q2 2026, Q1 2026, and Q4 2025 respectively.